These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 35365161)
1. The roles of CC chemokines in response to radiation. Wang L; Jiang J; Chen Y; Jia Q; Chu Q Radiat Oncol; 2022 Apr; 17(1):63. PubMed ID: 35365161 [TBL] [Abstract][Full Text] [Related]
2. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. Korbecki J; Kojder K; Simińska D; Bohatyrewicz R; Gutowska I; Chlubek D; Baranowska-Bosiacka I Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182504 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor-A Literature Review. Korbecki J; Kojder K; Barczak K; Simińska D; Gutowska I; Chlubek D; Baranowska-Bosiacka I Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781743 [TBL] [Abstract][Full Text] [Related]
4. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Korbecki J; Grochans S; Gutowska I; Barczak K; Baranowska-Bosiacka I Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076281 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and immunotherapy: a beneficial liaison? Weichselbaum RR; Liang H; Deng L; Fu YX Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262 [TBL] [Abstract][Full Text] [Related]
6. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy. Morein D; Erlichman N; Ben-Baruch A Front Immunol; 2020; 11():952. PubMed ID: 32582148 [TBL] [Abstract][Full Text] [Related]
10. Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment. Weiss JM; Back TC; Scarzello AJ; Subleski JJ; Hall VL; Stauffer JK; Chen X; Micic D; Alderson K; Murphy WJ; Wiltrout RH Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19455-60. PubMed ID: 19892741 [TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment. Cardoso AP; Pinto ML; Castro F; Costa ÂM; Marques-Magalhães Â; Canha-Borges A; Cruz T; Velho S; Oliveira MJ Cytokine Growth Factor Rev; 2021 Aug; 60():107-119. PubMed ID: 33863622 [TBL] [Abstract][Full Text] [Related]
12. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1 Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272 [TBL] [Abstract][Full Text] [Related]
13. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nagarsheth N; Wicha MS; Zou W Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670 [TBL] [Abstract][Full Text] [Related]
14. Chemokine-protease interactions in cancer. Van Damme J; Struyf S; Opdenakker G Semin Cancer Biol; 2004 Jun; 14(3):201-8. PubMed ID: 15246056 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota modulate T cell trafficking into human colorectal cancer. Cremonesi E; Governa V; Garzon JFG; Mele V; Amicarella F; Muraro MG; Trella E; Galati-Fournier V; Oertli D; Däster SR; Droeser RA; Weixler B; Bolli M; Rosso R; Nitsche U; Khanna N; Egli A; Keck S; Slotta-Huspenina J; Terracciano LM; Zajac P; Spagnoli GC; Eppenberger-Castori S; Janssen KP; Borsig L; Iezzi G Gut; 2018 Nov; 67(11):1984-1994. PubMed ID: 29437871 [TBL] [Abstract][Full Text] [Related]
16. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets. Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895 [TBL] [Abstract][Full Text] [Related]
17. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients. Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921 [TBL] [Abstract][Full Text] [Related]
18. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Soria G; Ben-Baruch A Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751 [TBL] [Abstract][Full Text] [Related]
19. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer. De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802 [TBL] [Abstract][Full Text] [Related]
20. How chemokines organize the tumour microenvironment. Mempel TR; Lill JK; Altenburger LM Nat Rev Cancer; 2024 Jan; 24(1):28-50. PubMed ID: 38066335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]